111 related articles for article (PubMed ID: 37664931)
1. SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer.
Wu C; Zhu X; Dai Q; Chu Z; Yang S; Dong Z
Front Biosci (Landmark Ed); 2023 Aug; 28(8):192. PubMed ID: 37664931
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1.
Liang M; Melchior F; Feng XH; Lin X
J Biol Chem; 2004 May; 279(22):22857-65. PubMed ID: 15028714
[TBL] [Abstract][Full Text] [Related]
3. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
[TBL] [Abstract][Full Text] [Related]
4. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
[TBL] [Abstract][Full Text] [Related]
5. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
[TBL] [Abstract][Full Text] [Related]
6. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
7. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
8. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
9. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation of PCNA by PIAS1 and PIAS4 promotes template switch in the chicken and human B cell lines.
Mohiuddin M; Evans TJ; Rahman MM; Keka IS; Tsuda M; Sasanuma H; Takeda S
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12793-12798. PubMed ID: 30487218
[TBL] [Abstract][Full Text] [Related]
11. PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.
Yang N; Zhao B; Rasul A; Qin H; Li J; Li X
Cell Death Dis; 2013 Sep; 4(9):e811. PubMed ID: 24052079
[TBL] [Abstract][Full Text] [Related]
12. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
13. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
16. Tumor Suppressor p14ARF Enhances IFN-γ-Activated Immune Response by Inhibiting PIAS1 via SUMOylation.
Alagu J; Itahana Y; Sim F; Chao SH; Bi X; Itahana K
J Immunol; 2018 Jul; 201(2):451-464. PubMed ID: 29848755
[TBL] [Abstract][Full Text] [Related]
17. Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.
Netherton SJ; Bonni S
PLoS One; 2010 Nov; 5(11):e13971. PubMed ID: 21103059
[TBL] [Abstract][Full Text] [Related]
18. Smad4 SUMOylation is essential for memory formation through upregulation of the skeletal myopathy gene TPM2.
Hsu WL; Ma YL; Liu YC; Lee EHY
BMC Biol; 2017 Nov; 15(1):112. PubMed ID: 29183317
[TBL] [Abstract][Full Text] [Related]
19. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
